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A B S T R A C T
The aim of the study was to determine the prevalence of contact sensitivity in patients with leg ulcers, and possible dif-
ference in the rate of contact hypersensitivity to standard series of allergens used in patch testing, and to particular topi-
cal agents used in local therapy of leg ulcers in special series, patients with and without atopy. The study included 60 pa-
tients, 45 female and 15 male, aged 37–85 (mean 68.37 female and 51.13 male), 30 of them with and 30 without allergic
contact dermatitis (ACD) of the leg (control group). The mean duration of leg ulceration was 5.62 years. The two groups
of patients underwent testing to standard series allergens and target series allergens including mupirocin, bepanthene,
silver sulfadiazine, chloramphenicol + clostridiopeptidase, betamethasone dipropionate, hydrocortisone + oxytetracy-
cline, momethasone, alginate, hydrocolloid, lanolin, pyrogallol, Vaseline, permanganate, Rivanol, povidone-iodine, gen-
tamicin, i.e. local agents most frequently used by the patients. Contact allergic hypersensitivity to standard series aller-
gens was demonstrated in 25 patients with a total of 49 positive reactions and a mean of 1.6 reactions per patient.
Positive reactions were most commonly recorded to balsam of Peru, fragrance mix and neomycin sulfate. There were 12
positive reactions to target series allergens, mean 0.4 reactions per patient. Forty-five positive reactions, mean 0.1 reac-
tions per patient, were recorded in the control group. Positive reactions were most commonly demonstrated to cortico-
steroid ointments, lanolin and bepanthene. Study results did not confirm a statistically significantly higher rate of sensi-
tization to particular topical agents frequently used in the treatment of patients with venous ulcers. Patch testing to
standard and special series allergens should be performed in case of prolonged leg ulcer epithelization.
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Introduction
Allergic contact dermatitis (ACD) is inflammatory
dermatosis of allergic genesis that occurs consequently to
low molecular mass substances (haptens, contact aller-
gens)1,2. The main pathogenetic mechanism is delayed
sensitivity (type IV reaction according to Coombs and
Gell) demonstrated by skin patch test3. The pathogenesis
of ACD is predominated by cellular immune reaction,
which implies a number of factors from the allergen
through the skin lymphoid system to cellular infiltrate
consisting of Langerhans cells, T lymphocytes, B lym-
phocytes, keratinocytes, macrophages and basophil leu-
kocytes4. It is estimated that more than six million chem-
icals are present in the environment, some 3000 of which
may act as contact sensitizers. Almost every inorganic
substance may induce delayed allergic inflammatory re-
action, i.e. dermatitis5.
The diagnosis of ACD is based on clinical picture and
positive patch test findings. The cause of allergic contact
dermatitis can frequently be suspected by analysis of the
distribution and appearance of lesions in combination
with patient history data. However, in most cases these
are inadequate to determine the etiologic agent, which
requires additional functional testing to verify the exis-
tence of sensitization. Patch test is a gold standard diag-
nostic procedure used for long time in dermatology and
allergology to relate contact hypersensitivity, introduced
as the patch test method by Jadassohn and Bloch in
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1895. Positive allergic test reaction includes pruritus, er-
ythema, papules, infiltrate, and occasionally vesicles at
the site of contact with the respective allergen. The reac-
tion may persist for several days. Initial reading is done
at 48 h, second at 72 h and third at 96 h, according Inter-
national Contact Dermatitis Research group. Some sub-
stances such as neomycin and corticosteroids may pro-
duce positive reaction only after 4–6 days, thus the last
reading is done after 7 days5,6. In patients with ACD
demonstrated by patch test, appropriate therapy results
in a considerably better improvement of skin lesions
than in those without patch test allergen identification7.
Patients and Methods
Study population included a randomized sample of 60
inpatients with venous leg ulcer, 30 with ACD and 30
without signs of contact allergy on the skin around leg
ulcers. Based to questionnaire all 60 patients atopy his-
tory, underwent bacteriologic and mycologic analysis of
the ulcer and surrounding skin, performed according to
standard principles, and patch testing to standard and
special series of allergens. Patch testing was performed
according to the International Contact Dermatitis Re-
search Group (ICDRG) recommendations using a stan-
dard series of contact allergens and target series aller-
gens. The standard series allergens (n=24) at nontoxic
concentrations of up to 2% in Vaseline or water included
the following: potassium bichromate, cobalt chloride,
nickel sulfate, formaldehyde, paraphenylenediamine,
balsam of Peru, epoxy resins, colophony, white mercury
precipitate, Anestesin (benzocaine), carba compounds,
mercapto compounds, black gum mix (PPD mix), fra-
grance mix, thiuram compounds, coal tars, parabene
mix, neomycin sulfate, Quaternium-15, thimerosal, Vim
(cleaning agent), Ariel and Faks (laundry detergents),
and ^arli (dish-washing liquid). Our own special series
allergens contained 16 agents and drugs used by the pa-
tients in the treatment of their leg ulcers (according to
patient history data): mupirocin, bepanthene, silver sul-
fadiazine, chloramphenicol + clostridiopeptidase, beta-
methasone dipropionate, hydrocortisone + oxytetracy-
cline, mometasone, alginate, hydrocolloid, lanolin, pyro-
gallol, Vaseline, permanganate, Rivanol, povidone-iodi-
ne, and gentamycin. The special series allergens were
prepared at concentrations recommended by ICDRG.
Patch testing was performed on the patient back skin,
with reading at 48, 72 and 96 h according to ICDRG cri-
teria.
The 2-test and Mann-Whitney U test were used on
statistical analysis.
Results
The study included 60 patients (45 female and 15
male), 30 with ACD and 30 free from signs of allergic sen-
sitization on their legs, aged 37–85, mean age 64.06
(68.37 female and 51.13 male). Leg ulcer duration of up
to one year was most commonly reported (n=27), how-
ever, five patients reported on 30-year persistence. Un-
derlying allergy and atopy were reported by 24 ACD pa-
tients and 20 non-ACD patients (control group) (Fig. 1).
In the group of ACD patients, Pseudomonas aeru-
ginosa was the most commonly isolated agent (n=13),
followed by Streptococcus epidermidis (n=12). In the
control group, Staphylococcus aureus was the most com-
monly isolated agent. Native and culture mycological
findings of leg ulcer swabs were negative in all 60 pa-
tients. Mycological examination of the skin surrounding
leg ulcer was also negative in all 60 patients. Results of
patch testing to standard series allergens in 30 ACD and
30 non-ACD patients are presented in Table 1. In the
group of 30 ACD patients, the most common standard se-
ries allergens were balsam of Peru, fragrance mix and
neomycin sulfate (n=8 each), followed by parabene mix
(n=7) and coal tars (n=4). In the control group, the most
common standard series allergens were neomycin sulfate
(n=6), balsam of Peru (n=4) and parabene mix (n=4).
2-test for correlation between contact sensitization and
standard series allergens yielded a statistically signifi-
cant difference for fragrance mix at the 5% level of signif-
icance. Special series allergens identified in ACD and
non-ACD patients are shown in Table 2. In the group of
30 ACD patients, the following target series allergens
were identified: hydrocortisone + oxytetracycline, lano-
lin, Rivanol, betamethasone dipropionate and bepan-
thene (n=2 each), followed by povidone-iodine and al-
ginates (n=1 each). In the control group, the following
target series allergens were identified: lanolin (n=2),
betamethasone dipropionate, bepanthene and mometa-
sone (n=1 each). 2-test for correlation between contact
sensitization and target series allergens showed no sta-
tistically significant difference for any of the allergens
tested.
In the study group as a whole (N=60), neomycin sul-
fate, fragrance mix, balsam of Peru, parabene mix and
coal tars were the most common allergens, all five being
common sensitizing agents found in topical medicinal
products. According to study results, lanolin showed a
comparable frequency in both ACD and control groups of
patients, whereas the remaining four allergens yielded
significant between-group differences. The distribution
of allergens across all 60 patients is presented in Table 3.
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Fig. 1. Prevalence of atopy in 60 patients according
to questionnaire.
Six ACD patients and 17 control patients showed nega-
tive patch test reaction. One patient from either group
showed positive reaction to six allergens without possible
angry back reaction.
Patch test results according to the duration of leg ul-
cer are shown in Table 4. Leg ulcers persisting for more
than one year were recorded in as many as 28 patients, in
16 of them for 2 to 5 years. Comparison of the rate of con-
tact sensitization between leg ulcer patients with and
without a history of allergic diseases by 2-test yielded no
statistically significant difference (2=1.36; p=0.2429).
The rate of positive patch test results was significantly
higher in patients with dermatitis affecting the skin
around leg ulcer than in those without such perilesional
skin changes.
Contact hypersensitivity to medicament ingredients
and bases for topical agents was quite common in our leg
ulcer patients. Positive reaction was most frequently ob-
served to neomycin, fragrance mix and balsam of Peru of
the standard series, and to corticosteroid ointments in
combination with antibiotics, and lanolin of the target
series allergens.
In our patient sample, the rate of sensitization was
comparable to that reported elsewhere. It was more fre-
quent in patients with longstanding or recurrent leg ul-
cers. The study confirmed the polyvalent sensitization,
i.e. hypersensitivity to multiple substances, to be quite
common in patients with persistent leg ulcers, in those
with inflammation of the skin around the ulcer as well as
in some patients free from such lesions.
Discussion
Contact allergic dermatitis has for years been known
to occur in patients with venous ulcers and hypostatic
dermatitis, the issue being investigated in numerous
studies. Besides contact dermatitis, the area around the
ulcer may also be involved by bacterial or fungal coloni-
zation. In the present study, the bacterial agents Pseudo-
monas aeruginosa, Staphylococcus epidermidis, Staphy-
lococcus aureus and others were isolated in both ACD
and non-ADC patient groups. Most authors report on
gram-negative microorganisms and streptococci as the
most common wound swab isolates8–10, which is consis-
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TABLE 1
PATCH TEST RESULTS IN 60 PATIENTS TESTED TO STANDARD SERIES ALLERGENS
No. Allergen Concentration (%)
No. of positive tests reactions
ACD Control group Total (%)
1 Potassium dichromate 0.5 % pet. 1 0 1.6
2 Cobalt chloride 1.0 % pet. 0 0 0
3 Nickel sulfate 5.0 % pet. 1 0 1.6
4 Formaldehyde 1.0 % aq 0 1 1.6
5 Paraphenylenediamine 0.5 % pet. 1 1 3.33
6 Balsam of Peru 25.0 % pet. 8 4 20
7 Epoxy resin 1.0 % pet. 1 0 1.6
8 Colophony 20.0 % pet. 2 0 3.33
9 White mercury precipitate 10.0 % pet. 1 1 3.33
10 Anestesin (benzocaine) 5.0 % pet. 1 0 1.6
11 Carba mix 3.0 % pet. 1 2 5
12 Mercapto mix 2.0 % pet. 0 1 1.6
13 PPD-mix 0.6 % pet. 2 1 3
14 Fragrance mix 8.0 % pet. 8 2 16
15 Thiuram mix 1.0 % pet. 2 2 5
16 Coal tars 12.0 % pet. 4 2 10
17 Parabene mix 15.0 % pet. 7 4 18.3
18 Neomycin sulfate 20.0 % pet. 8 6 23.3
19 Quaternium-15 1.0 % pet. 0 0 0
20 Thimerosal 0.1 % pet. 0 1 1.6
21 Vim (cleaner) 2.0 % pet. 0 0 0
22 Ariel detergent 2.0 % pet. 0 0 0
23 ^arli detergent 2.0 % pet. 0 0 0
24 Faks detergent 2.0 % pet. 1 1 1.6
ACD – allergic contact dermatitis group, pet. – petrolatum, aq – water
tent with our results. Fungal agents were excluded in
and around the wound, thus ruling out the possible effect
of dermatophytes and yeasts in inflammatory reaction in
both ACD and non-ACD patient groups.
In the ACD group, 25/30 patients showed single or
multiple positive patch test reactions. Patch testing to
standard series allergens produced a total of 49 positive
reactions in ACD patients, mean 1.6% per patient. Posi-
tive reactions were most frequently recorded to balsam
of Peru, fragrance mix, and neomycin sulfate. The rate of
sensitization to standard series allergens was 76%. These
results are comparable to those reported in the lite-
rature11–17. In the control group of patients free from
signs of contact sensitization (non-ACD group) there
were 29 positive patch test reactions, most frequently to
neomycin sulfate.
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TABLE 2
PATCH TEST RESULTS IN 60 PATIENTS TESTED TO SPECIAL SERIES OF ALLERGENS
No. Allergen Concentration
No. of positive reactions
ACD Control group Total (%)
1 Mupirocin Conc 0 0 0
2 Bepanthene Conc 2 1 5
3 Silver sulfadiazine 2% pet. 0 0 0
4 Chloramphenicol+clostridiopeptidase 5% pet. 0 0 0
5 Betamethasone dipropionate Conc 2 1 5
6 Hydrocortisone+oxytetracycline 1% pet. 2 0 3.33
7 Mometasone Conc 0 1 1.6
8 Alginate dressing Conc 1 0 1.6
9 Hydrocolloid Conc 0 0 0
10 Lanolin 20% pet. 2 2 6.66
11 Pyrogallol 1% pet. 0 0 0
12 Vaseline Conc 0 0 0
13 Permanganate 1% aq 0 0 0
14 Rivanol 2% aq 2 0 3.33
15 Povidone-iodine 2% aq 1 0 1.66
16 Gentamicin Conc 0 0 0
ACD – allergic contact dermatitis group, pet. – petrolatum, aq – water
TABLE 4





Total number of positive patch test results
0 1 2 3 4 5 6 7 8
<1 28 16 4 3 1 1 0 2 0 1
2–5 16 7 3 1 3 0 1 1 0 0
6–10 7 0 2 3 0 0 2 0 0 0
11–15 2 0 1 0 1 0 0 0 0 0
16–20 1 0 0 1 0 0 0 0 0 0
21–25 3 0 0 2 1 0 0 0 0 0
25–30 3 0 2 0 1 0 0 0 0 0
31–35 1 0 0 0 1 0 0 0 0 0
TABLE 3
DISTRIBUTION OF MONO- AND POLYSENSITIZATION IN







All negative 6 17
One positive 6 6
Two positive 8 2
Three positive 6 2
Four positive 0 1
Five positive 3 0
Six positive 1 1
Eight positive 0 1
Patch testing to special series allergens including top-
ical agents (ointments, creams, dressings) produced 12
(3%) positive reactions in ACD patients, mean 0.4% per
patient. In the control group of patients free from signs
of contact sensitization (non-ACD), there were 5 positive
patch test reactions, mean 0.1% per patient. Positive
patch test reactions were most commonly recorded to
corticosteroid ointments (betamethasone dipropionate,
hydrocortisone, oxytetracycline), lanolin, and bepanthe-
ne. Allergic reactions to these agents are frequently ob-
served in practice. We also included hydrocolloids and
alginates, relatively new agents, reported to have been
used by our patients over a period preceding the study.
Special series allergens included local corticosteroid agents,
which have recently been extensively investigated18–23.
Antibiotics intended for local application frequently
cause contact hypersensitivity, as preceeding in a num-
ber of studies11–14. Our patients were tested for neomy-
cin, mupirocin, and oxytetracycline as a constituent of
Geokorton ointment frequently applied around leg ul-
cers. Hypersensitivity to an antibiotic or corticosteroid in
a combined product is difficult to assess, pointing to the
importance of using monocomponent products on test-
ing. In most studies, neomycin sensitization in patients
with leg ulcer and stasis dermatitis ranges between 3%
and 19%11–14, whereas in our study it was 2.6%. Although
antibiotics have long been known to frequently induce
sensitization, they are still quite commonly and abun-
dantly used in the management of venous ulcers, being
unjustifiably applied over the wound or on the adjacent
skin. While cross-reactivity between aminoglycoside an-
tibiotics is well known, it was not demonstrated in the
present study. We recorded positive reaction to neomycin
but not to geomycin in the form of gentamycin ointment.
Target series allergens included mupirocin, which is con-
sidered to very infrequently lead to sensitization. It was
confirmed in this study, as none of the study patients ex-
hibited sensitization to mupirocin.
The use of antiseptic dressings such as povidone-io-
dine can successfully reduce bacterial colonization, elimi-
nate malodor, and clean the wound at a low risk of
sensitization24–27. According to Mochida et al., ACD to io-
dine products is extremely rare, so an irritative or sys-
temic reaction should rather be expected26.
Our patients showed quite a high rate of positive reac-
tions to fragrance mix. When ACD due to drugs or cos-
metic products is suspected, patients should primarily be
tested to fragrance mix. Numerous components of fra-
grance products may act as potent sensitizers, thus their
application over inflamed and irritated skin should be
avoided27. Fragrances are frequently used in officinal and
magistral products for local application. Balsam of Peru is
another common cause of contact allergic dermatitis. The
rate of sensitization to balsam of Peru varies; however,
most authors agree it is a common allergen with a rising
tendency of positive reactions. Balsam of Peru is an ingre-
dient found in many products for topical therapy of
wounds, burns or pruritus as well as in sunscreens. In pa-
tients with leg ulcer, the rate of sensitization to balsam of
Peru is threefold that recorded in other patients28–30.
According to many authors, hypersensitivity to beta-
methasone dipropionate is very common. Hydrocortisone
is a common contact allergen.
Lepoittevin et al. report on their observation that
many patients are allergic to multiple local corticoste-
roids. They have adopted and recommended classifica-
tion into four groups, concluding that allergic reactions
to tixocortol pivalate and hydrocortisone are definitely
associated, whereas reactions to butesonide strongly cor-
relate with acetonide group and ester group31. Burden
and Beck estimate the prevalence of corticosteroid hy-
persensitivity at 4%–9% and believe that this type of al-
lergy frequently remains unrecognized, therefore sug-
gesting the test to corticosteroid agents to be included in
routine patch testing32. On testing with corticosteroids,
however, numerous reactions emerging from local prod-
uct basis may pose a serious problem33.
In special series allergens, we recorded two (6.66%)
positive reactions to lanolin, a common ingredient in top-
ical medicinal and cosmetic products. According to litera-
ture reports, the rate of sensitization to lanolin ranges
from 1.7% to 30%34. Negative reactions to hydrocolloid
products and alginates observed in both ACD and non-
ACD groups of patients could be explained by the rela-
tively short and not very frequent use of these products
in our patients. The reason for our negative results to
dressings probably lies in considerably shorter applica-
tion than recommended for particular agents35.
The standard series allergens used in the study in-
cluded thimerosal, a mercury chromium derivative, fre-
quently used as a preservative in various topical medici-
nal and cosmetic products. Mercury chromium used to be
frequently utilized in the treatment of ulcer36,37. None of
our study patients showed positive reaction to thime-
rosal.
The results of the present study revealed that contact
sensitization associated with venous ulcer treatment
presented a considerable problem in our patients as well.
Early patch testing allowed for timely identification of al-
lergens and thus to avoid contact with particular aller-
gens, thereby hopefully contributing to successful cure.
Highly indifferent products and those of known basis
free from preservatives should be locally applied on ul-
cers, thus reducing the rate of ACD, which causes addi-
tional discomfort to the patient. Awareness and avoid-
ance of thus identified allergens along with early
diagnosis of contact allergic sensitization offer a success-
ful therapeutic option for leg ulcers.
Conclusion
During the treatment of leg ulcers, the possible exis-
tence of contact sensitization should be considered, ap-
propriate testing indicated, and potential allergens iden-
tified on time, as it is a precondition for successful cure of
leg ulcer. The products known to cause frequent sensiti-
zation and the bases containing lanolin should be avoi-
ded. Topical products free from fragrance mixture should
be used.
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KONTAKTNA ALERGIJA NA SPECIJALNE I STANDARDNE ALERGENE KOD
PACIJENATA S VENOZNIM ^IREVIMA
S A @ E T A K
Cilj je studije bio odrediti u~estalost kontaktne preosjetljivosti u bolesnika s vrijedom na potkoljenicama. Ustanoviti
razliku kontaktne senzibilizaciju na alergene epikutane standardne serije u odnosu na mogu}e alergene iz lokalne
terapije koja je primjenjivana u bolesnika. U istra`ivanje je uklju~eno 60 bolesnika, 45 `ene i 15 mu{karaca u dobi 37 do
85 godina (prosje~na do za `ene je 68.37 i za mu{karce 51.13 godina). Kontaktni alergijski dermatitis (KAD) je imalo 30
bolesnika na potkoljenicama, a 30 je bilo bez KAD-a (kontrolna skupina). Prosje~no trajanje vrijeda bilo 5.62 godine. Svi
su bolesnici testirani na alergene standardne serije kao i ciljane serije alergena koju sa~injava: mupirocin, bepanten,
srebrni sulfadiazin, kloramfenikol + klostridiopeptidaza, betametazon dipropionat, hidrokortizon + oksitetraciklin,
mometazon, alginat, hidrokoloid, lanolin, pirogalol, vazelin, hipermangan, rivanol, povidon jodid, gentamicin, koji su
bolesnici upotrebljavali pri lije~enju vrijeda. KAD na alergene standardne serije utvr|en je u 25 bolesnika s ukupno 49
pozitivne reakcije i prosje~no 1.6 reakcija po bolesniku. Naj~e{}i alergeni bili su: Peruvijanski balzam, smjesa mirisa i
neomicin sulfat. Utvr|eno je 12 pozitivnih reakcija na alergene ciljane serije s prosje~no po bolesniku 0.4 pozitivne
reakcije. U kontrolnoj skupini bilo je 45 pozitivnih reakcija s prosje~no 0.1 reakcija po bolesniku. Naj~e{}i alergeni bili
su kortikosteroidne masti, lanolin i bepanten. Ovo istra`ivanje nije potvrdili statisti~ki zna~ajno ve}i postotak preosjet-
ljivosti na primijenjene tvari koje su kori{tene u lije~enju bolesnika s vrijedom na potkoljenicama. Epikutano testiranje
na standardnu i ciljanu seriju alergena treba primijeniti u slu~ajevima kada je spora epitelizacija vrijeda.
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